Literature DB >> 23176750

Genetic analysis of NFE2L2 promoter variation in Taiwanese Parkinson's disease.

Yi-Chun Chen1, Yih-Ru Wu, Yi-Ci Wu, Guey-Jen Lee-Chen, Chiung-Mei Chen.   

Abstract

Oxidative stress has been reported as one of the pathogeneses of Parkinson's disease (PD). Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor that regulates the expression of the target genes involved in antioxidant pathway. The promoter polymorphisms of the Nrf2-encoding gene, NFE2L2, have been shown to affect the promoter activity. Inconsistent findings of the associations between NFE2L2 promoter polymorphisms and PD have been reported in a multiple candidate gene study, a whole-genome association study, and a case-control study in multiple ethnicity groups. This study enrolled a total of 1006 individuals composed of 480 PD patients and 526 controls to evaluate if there was an association of the NFE2L2 promoter polymorphisms with PD susceptibility in the Taiwan population. Three promoter single nucleotide polymorphisms (SNPs) rs35652124, rs6706649, and rs6721961 were examined using polymerase chain reaction and restriction analysis. The associations of each of the SNPs and the haplotypes constructed by the variations with PD susceptibility were examined. In spite of adequate statistic power, we observe no association of the three SNPs and their haplotypes with PD in a Taiwanese population. One of the reasons for the association disparity may include the genomic differences in ethnicities and environmental factors in different geographical regions.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23176750     DOI: 10.1016/j.parkreldis.2012.10.018

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  8 in total

Review 1.  Nrf2/ARE Pathway as a Therapeutic Target for the Treatment of Parkinson Diseases.

Authors:  Artem P Gureev; Vasily N Popov
Journal:  Neurochem Res       Date:  2019-01-07       Impact factor: 3.996

Review 2.  Nrf2--a therapeutic target for the treatment of neurodegenerative diseases.

Authors:  Delinda A Johnson; Jeffrey A Johnson
Journal:  Free Radic Biol Med       Date:  2015-08-14       Impact factor: 7.376

Review 3.  Nrf2: a modulator of Parkinson's disease?

Authors:  Michael Todorovic; Stephen A Wood; George D Mellick
Journal:  J Neural Transm (Vienna)       Date:  2016-05-04       Impact factor: 3.575

4.  Comprehensive assessment of genetic sequence variants in the antioxidant 'master regulator' NRF2 in idiopathic Parkinson's disease.

Authors:  Michael Todorovic; Jeremy R B Newman; Jianguo Shan; Steven Bentley; Stephen A Wood; Peter A Silburn; George D Mellick
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

5.  Nrf2 and redox status in prediabetic and diabetic patients.

Authors:  Angélica S Jiménez-Osorio; Alejandra Picazo; Susana González-Reyes; Diana Barrera-Oviedo; Martha E Rodríguez-Arellano; José Pedraza-Chaverri
Journal:  Int J Mol Sci       Date:  2014-11-06       Impact factor: 5.923

6.  Genetic Variations and mRNA Expression of NRF2 in Parkinson's Disease.

Authors:  Caroline Ran; Karin Wirdefeldt; Lovisa Brodin; Mehrafarin Ramezani; Marie Westerlund; Fengqing Xiang; Anna Anvret; Thomas Willows; Olof Sydow; Anders Johansson; Dagmar Galter; Per Svenningsson; Andrea Carmine Belin
Journal:  Parkinsons Dis       Date:  2017-05-02

7.  Genetic associations of Nrf2-encoding NFE2L2 variants with Parkinson's disease - a multicenter study.

Authors:  Malin von Otter; Petra Bergström; Aldo Quattrone; Elvira Valeria De Marco; Grazia Annesi; Peter Söderkvist; Stephanie Bezzina Wettinger; Marek Drozdzik; Monika Bialecka; Hans Nissbrandt; Christine Klein; Michael Nilsson; Ola Hammarsten; Staffan Nilsson; Henrik Zetterberg
Journal:  BMC Med Genet       Date:  2014-12-12       Impact factor: 2.103

8.  Genetic variants of nuclear factor erythroid-derived 2-like 2 associated with the complications in Han descents with type 2 diabetes mellitus of Northeast China.

Authors:  Xiaohong Xu; Jing Sun; Xiaomin Chang; Ji Wang; Manyu Luo; Kupper A Wintergerst; Lining Miao; Lu Cai
Journal:  J Cell Mol Med       Date:  2016-07-04       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.